Literature DB >> 21538804

BMPR-II is dispensable for formation of the limb skeleton.

Laura W Gamer, Kunikazu Tsuji, Karen Cox, Luciane P Capelo, Jonathan Lowery, Hideyuki Beppu, Vicki Rosen.   

Abstract

Initiation of BMP signaling is dependent upon activation of Type I BMP receptor by constitutively active Type II BMP receptor. Three Type II BMP receptors have been identified; Acvr2a and Acvr2b serve as receptors for BMPs and for activin-like ligands whereas BMPR-II functions only as a BMP receptor. As BMP signaling is required for endochondral ossification and loss of either Acvr2a or Acvr2b is not associated with deficits in limb development, we hypothesized that BMPR-II would be essential for BMP signaling during skeletogenesis. We removed BMPR-II from early limb mesoderm by crossing BMPR-II floxed mice with those carrying the Prx1-Cre transgene. Mice lacking limb expression of BMPR-II have normal skeletons that could not be distinguished from control littermates. From these data, we conclude that BMPR-II is not required for endochondral ossification in the limb where loss of BMPR-II may be compensated by BMP utilization of Acvr2a and Acvr2b.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538804     DOI: 10.1002/dvg.20761

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  10 in total

1.  BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b.

Authors:  Shoichiro Kokabu; Laura Gamer; Karen Cox; Jonathan Lowery; Kunikazu Tsuji; Regina Raz; Aris Economides; Takenobu Katagiri; Vicki Rosen
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.

Authors:  Jonathan W Lowery; Giuseppe Intini; Laura Gamer; Sutada Lotinun; Valerie S Salazar; Satoshi Ote; Karen Cox; Roland Baron; Vicki Rosen
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

3.  N-linked glycosylation of the bone morphogenetic protein receptor type 2 (BMPR2) enhances ligand binding.

Authors:  Jonathan W Lowery; Jose M Amich; Alex Andonian; Vicki Rosen
Journal:  Cell Mol Life Sci       Date:  2013-12-15       Impact factor: 9.261

4.  BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation.

Authors:  Michael W Pickup; Laura D Hover; Eleanor R Polikowsky; Anna Chytil; Agnieszka E Gorska; Sergey V Novitskiy; Harold L Moses; Philip Owens
Journal:  Mol Oncol       Date:  2014-08-23       Impact factor: 6.603

5.  BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma.

Authors:  Amy L Strong; Philip J Spreadborough; Devaveena Dey; Peiran Yang; Shuli Li; Arthur Lee; Ryan M Haskins; Patrick D Grimm; Ravi Kumar; Matthew J Bradley; Paul B Yu; Benjamin Levi; Thomas A Davis
Journal:  Stem Cells Dev       Date:  2020-12-24       Impact factor: 3.272

Review 6.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

7.  BMPR2 inhibition induced apoptosis and autophagy via destabilization of XIAP in human chondrosarcoma cells.

Authors:  G Jiao; W Guo; T Ren; Q Lu; Y Sun; W Liang; C Ren; K Yang; K Sun
Journal:  Cell Death Dis       Date:  2014-12-11       Impact factor: 8.469

Review 8.  Mesenchymal Stem Cell-Derived Extracellular Vesicles for Bone Defect Repair.

Authors:  Dongxue Wang; Hong Cao; Weizhong Hua; Lu Gao; Yu Yuan; Xuchang Zhou; Zhipeng Zeng
Journal:  Membranes (Basel)       Date:  2022-07-19

9.  Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP).

Authors:  O Will Towler; Sun H Peck; Frederick S Kaplan; Eileen M Shore
Journal:  Dev Biol       Date:  2020-11-17       Impact factor: 3.582

Review 10.  BMP Signaling in the Development and Regeneration of Cranium Bones and Maintenance of Calvarial Stem Cells.

Authors:  Guiqian Chen; Haodong Xu; Yifeng Yao; Tingting Xu; Mengting Yuan; Xingen Zhang; Zhengbing Lv; Mengrui Wu
Journal:  Front Cell Dev Biol       Date:  2020-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.